— Know what they know.
Not Investment Advice

FNA NYSE

Paragon 28, Inc.
1W: +0.5% 1M: +0.5% 3M: +22.8% 1Y: +35.8% 3Y: -18.4%
$13.09
Last traded 2025-04-17 — delisted
NYSE · Healthcare · Medical - Devices · $1.1B mcap · 44M float · 5.82% daily turnover · Short 56% of daily vol
Smart Money Score
Watch 0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.1B
52W Range4.65-13.13
Volume16,574,214
Avg Volume2,570,028
Beta1.47
Dividend—
Analyst Ratings
3 Buy 4 Hold 0 Sell
Consensus Hold
Company Info
CEOAlbert DaCosta
Employees525
SectorHealthcare
IndustryMedical - Devices
IPO Date2021-10-15
14445 Grasslands Drive
Englewood, CO 80112
US
730 399 3400
About Paragon 28, Inc.

Paragon 28, Inc. is a medical device company specializing in the development, manufacturing, and global distribution of advanced surgical systems tailored for foot and ankle procedures. Its comprehensive product portfolio encompasses a wide array of solutions: Plating Systems: This includes the Gorilla plating series, offering specific solutions for Lisfranc injuries, Lapidus procedures, lateral column corrections, calcaneus slides, and naviculocuneiform (NC) fusions. Complementary products like Baby Gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates, as well as Silverback plating systems, are also available. Precision Guidance Technology: The company provides sophisticated guidance systems to enhance accuracy in various operations, such as fusion procedures for bunion deformities, first tarsometatarsal arthrodesis, metatarsal osteotomy for bunion correction, medial column beaming for Charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. Screw Systems: Paragon 28 offers robust screw systems, including the Monster, Mini Monster, and Joust beaming lines, which are critical for applications like bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, and fracture repair. Joint Replacement Solutions: Their offerings extend to total ankle replacement with the APEX 3D systems, alongside total talus spacers designed to replace the talus bone that links the leg and foot. Bunion/Hallux Valgus Correction Systems: Specifically for bunion management, the company provides nail systems such as the Phantom intramedullary nail systems, targeting severe hallux valgus cases. Orthobiologics: A substantial part of their product line comprises various orthobiologics, including bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix. They also feature PRESERVE bone graft systems for homologous applications. Ancillary Products: The company further supplies soft tissue fixation systems, titanium sprayed polyetheretherketone (PEEK) implants, nitinol staple systems, stabilization solutions, and specialized curved instruments. Paragon 28 distributes its products to hospitals and ambulatory surgery centers through an established network of both direct sales representatives and stocking distributors. Founded in 2010, the company maintains its corporate headquarters in Englewood, Colorado.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
McCormack Robert S D-Return 203,134 $13.00 2025-04-21
McCormack Robert S D-Return 20,014 — 2025-04-21
Scanlon Meghan D-Return 42,113 $13.00 2025-04-21
SCHNETTLER THOMAS P D-Return 45,035 $13.00 2025-04-21
Oesterle Stephen N. D-Return 250,000 $6.60 2025-04-21

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms